September 2012 Editor's Picks: Products from Uhlmann Packaging Systems and GE Healthcare - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

September 2012 Editor's Picks: Products from Uhlmann Packaging Systems and GE Healthcare

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Uhlmann Packaging Systems
Integrated blister and carton module features simplified changeover

Uhlmann Packaging Systems’ Blister Express Center 500 (BEC 500) is a double-lane, integrated blister and carton module that can process up to 500 blisters and 500 cartons per minute, which makes it ideal for packaging medium-sized batches of standard, solid-dose products. The flexible machine is available with rotary or platen sealing and can produce complex shapes, rigid aluminum pockets, calendar packs, and other nontraditional packages. Between runs, the machine features a newly simplified changeover process that allows a single person to completely reset the entire line in just 30 minutes without the use of tools. Uhlmann’s new SmartControl operating system offers step-by-step guidance through the entire format changeover.


GE Healthcare
Modular, prefabricated bioprocessing facility reduces construction time and capital investment compared to traditional facilities


GE Healthcare’s KUBio modular, 1200-m2 bioprocessing facility is prefabricated and delivered with a complete, ready-to-use production line that is based on GE Healthcare’s Ready-to-Process single-use technologies. The total planning, delivery, and construction time of the facility is 14–18 months, which is significantly less than the 24–36 months needed for traditional construction. Capital investment is also significantly reduced.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here